Do the authors of the IDSA guidelines for Lyme disease believe their own words? I thought these “experts” were infallible. Here are quotes from several of them that were published in credible, peer reviewed journals. “We studied 17 patients who had presented with acute Lyme disease and received prompt treatment with oral antibiotics, but in whom chronic Lyme disease subsequently developed” Raymond Dattwyler, John Halperin - New England Journal of Medicine, 1998 (319(22): 1441-6) “The relapses she repeatedly suffered despite initially successful antibiotic treatment could be related to the observation that Borrelia may possibly be able to remain dormant in certain tissue compartments, thus escaping bactericidal antibiotic activity.” Gerold Stanek – British Journal of Dermatology, 2001 (144(2):387-392 “…isolation of Borrelia burgdorferi from the blood of seven patients with Lyme disease four months after treatment…” Gary Wormser, Robert Nadelman - American Journal of Medicine, 1990 (88:21-26) “Lyme borreliosis is a chronic infectious disease caused by the spirochete Borrelia burgdorferi.” Raymond Dattwyler - Reviews of Infectious Diseases, 1989 [11(6)S6; S1494-8] “… commercially available FDA-approved kits are only 36-70% sensitive, : the ELISA assay does not have adequate sensitivity to be part of a two tiered approach to diagnosis.” John S. Bakken - Journal of Clinical Microbiology, 1997 [35(3): 537-543] “In many instances continued infection appears to be essential for symptoms to persist, no matter how small the number of organisms, as antimicrobial therapy is generally followed by clinical improvement.” John J. Halperin - Neurology, 1992 (42:43-50) “Currently, Lyme disease is treated with a range of antibiotics, e.g., tetracyclines, penicillin and cephalosporins. However, such treatment is not always successful in clearing the infection. Treatment is often delayed due to improper diagnosis with the deleterious effect that the infection proceeds to a chronic condition, where treatment with antibiotics is often not useful.” Raymond J. Dattwyler - Patent application for Lyme vaccine 2007. “57% of patients who had relapse were seronegative at the time of relapse.” Dattwyler RJ et al - Annals of Internal Medicine, 1996 124(9):785-91
Posted on: Fri, 28 Mar 2014 00:53:22 +0000
Trending Topics
Recently Viewed Topics
© 2015